A PROSPECTIVE CLINICAL STUDY ON DISEASE KNOWLEDGE AND MEDICATION ADHERENCE PATTERN AMONG ASTHMATIC PATIENTS IN TERTIARY CARE HOSPITAL IN A TIRUPUR POPULATION
Objectives: To study the disease knowledge and drug adherence among asthmatic patients in tertiary care hospital in a rural population.
Methods: A total of 99 patients with bronchial asthma study conducted in tertiary care hospital in rural population face to face interaction with patients follow-up have done for 4 months. This clinical study was administered with standard questionnaires evaluating the patient knowledge and medication adherence (MA) Morisky8-items MA scale toward asthma and treatment.
Results: A total of 99 patients were evaluated for this clinical study. 43.5% of the patients were male and 56.4% were female. The percentage of the mean score of knowledge and MA are 17% and 18%, with their standard deviation of 1.51 and 1.64, respectively.
Conclusion: This study demonstrated that the patientâ€™s specific knowledge regarding asthma was low. However, few patientâ€™s had favorable attitude toward their disease, but other did not have the necessary knowledge of disease management. In addition, the drug adherence was also poor in occupation induced asthmatics patients.
2. National Asthma Education and Prevention Program [NAEPP]. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2. NIH Publication No. 97-4051. Bethesda, MD: National Institutes of Health, National Heart Lung and Blood Institute; 1997.
3. National Asthma Campaign Asthma Audit. Out in the open: A true picture of asthma in the United Kingdom today. Asthma J 2001;6(3):S1-14.
4. Yunginger JW, Reed CE, Oâ€™Connell EJ, Melton LJ 3rd, Oâ€™Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis 1992;146(4):888-94.
5. Preston-Clark P, Primatesta P, editors. Health Survey for England. London: The Stationery Office; 1997.
6. Taylor AJ. Asthma. In: Warrell D, Cox TM, Firth JD, Benz EJ, editors. Textbook of Medicine. 4th ed. Oxford, UK: Oxford University Press; 2004. p. 17.12.
7. Kaplan AG, Balter MS, Bell AD, Kim H, McIvor RA. Diagnosis of asthma in adults. Can Med Assoc J 2009;181:E210-20.
8. Hoare J, Bruce M. Prevalence of treated asthma and its management in general practice in England and wales, 1994-98. National statistics. Health Stat Q 2003;17:15-22.
9. LarchÃ© M. Regulatory T cells in allergy and asthma. Chest 2007;132(3):1007-14.
10. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995;333(2):107-12.
11. Warren CP, Hargreave FE. Occupational asthma: Definition, diagnosis and management. CMAJ 1985;133(9):851-4, 875.
12. Newman Taylor AJ. Occupational asthma. Thorax 1980;35(4):241-5.
13. Chan-Yeung M, Malo JL. Aetiological agents in occupational asthma. Eur Respir J 1994;7(2):346-71.
14. Aliverti A, Rodger K, DellacÃ RL, Stevenson N, Lo Mauro A, Pedotti A, et al. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD. Thorax 2005;60(11):916-24.
15. Christiani DC, Eisen EA, Wegman DH, Ye TT, Gong ZC, Lu PL, et al. Respiratory disease in cotton textile workers in the peopleâ€™s republic of China. II. Pulmonary function results. Scand J Work Environ Health 1986;12(1):46-50.
16. Bateman ED, Bousquet J, Keech ML, Busse WW, Clark TJ, Pedersen SE. The correlation between asthma control and health status: The GOAL study. Eur Respir J 2007;29(1):56-62.
17. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials. Thorax 1992;47(2):76-83.
18. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170(8):836-44.
19. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test: A survey for assessing asthma control. J Allergy Clin Immunol 2004;113(1):59-65.
20. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention; 2009. Available from: http://www.ginasthma.com. [Last accessed on 2010 Jul 15].
21. Thoonen BP, Schermer TR, Van Den Boom G, Molema J, Folgering H, Akkermans RP, et al. Self-management of asthma in general practice, asthma control and quality of life: A randomised controlled trial. Thorax 2003;58(1):30-6.
22. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention; 2008. Available from: http://www.ginasthma.org. [Last updated on 2009 Dec; Last accessed on 2010 May].
23. Puhan MA, Gaspoz JM, Bridevaux PO, Schindler C, Ackermann-Liebrich U, Rochat T, et al. Comparing a disease-specific and a generic health-related quality of life instrument in subjects with asthma from the general population. Health Qual Life Outcomes 2008;6:15.
24. Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. Chest 2002;121(6):1824-32.
25. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24(1):67-74.
26. Carranza Rosenzweig JR, Edwards L, Lincourt W, Dorinsky P, ZuWallack RL. The relationship between health-related quality of life, lung function and daily symptoms in patients with persistent asthma. Respir Med 2004;98(12):1157-65.
27. Katz PP, Yelin EH, Eisner MD, Blanc PD. Perceived control of asthma and quality of life among adults with asthma. Ann Allergy Asthma Immunol 2002;89(3):251-8.
28. Schulz M, Verheyen F, MÃ¼hlig S, MÃ¼ller JM, MÃ¼hlbauer K, Knop-Schneickert E, et al. Pharmaceutical care services for asthma patients: A controlled intervention study. J Clin Pharmacol 2001;41(6):668-76.
29. Abdel-Hameed I, Ebid M, Abdel-Wahab E. Bronchial asthma and COPD: Impact of pharmaceutical care on outcomes and quality of life in Egyptian patients. Part 1. Bull Pharm Sci Assiut Univ 2006;29:167-85.
30. Kumar VB, Thankachan TM, Amanapu A, Chandra DS, Krishnan SP. Study of prescribing pattern and impact of pharmaceutical care in bronchial asthmatic paediatric patients in a tertiary care teaching hospital. Indian J Pharm Pract 2015;8(1):42-8.
31. Maazuddin M, Mohiuddin MN, Javeedullah M, Afreen S. Prescription monitoring of drugs used for asthma and COPD: A retrospective, before-after study. Int J Pharm Med Res 2014;2(2):43-8.
32. Mohamed HA, Al-Jaber MM, Al-Hamadani Z, Khmour HY, Al-Lenjawi BA, Schlogl JM. Prevalence of postnatal depression and associated risk factors among south Asian mothers living in a newly developing country. Asian J Pharm Clin Res 2016;9(6):57-61.
33. Maheshwari P, Ravichandiran V, Kumar KB, Sreelekha KV, Baig TS, Shahel SN. Prescribing patterns of antibiotics in paediatrics for respiratory tract infections/disorders in tertiary care hospital. Asian J Pharm Clin Res 2015;8(4):259-61.
34. Ahmad S, Ismail NE. A qualitative study exploring the impact of stigma in the lives of adult Asthma patients in Selangor Malaysia. Int J Pharm Pharm Sci 2015;7(7):373-5.
35. Giner J, Roura P, Torres B, Burgos F, Castillo D, Tarragona E, et al. Knowledge, attitudes and preferences among Spanish community pharmacists regarding inhaled therapy the optim pharmacy study. Int J Pharm Pharm Sci 2016;8(9):53-60.